Brand name
Verelan itself isn’t sold as a prescription anymore.
Generic name: verapamil
Used for: High blood pressure
From
$21.88 for 30 capsules
Generic verapamil DR with the free Team Cuban Card, at pharmacies that take it. Pick the strength on your label for its own price.
Rather have it mailed? From $60 for 30 capsules from Rx Outreach, by mail. Make a free account, then have your prescription sent there.
Open Rx OutreachA regular generic has the same active ingredient as Verelan, and the FDA requires it to work the same way.
Verelan itself isn’t sold as a prescription anymore.
The same medicine as Verelan, without the brand name
The same medicine as Verelan, without the brand name. Its NDC is the number that names the exact product: give it to the pharmacy and they can look it up or order it.
verapamil
Pick your strength
Give the pharmacy this NDC
What to say at the pharmacy
“Before you fill my Verelan, can you tell me what I’d pay for the brand, for the authorized generic from Wilshire Pharmaceuticals (NDC ), and for a regular generic?”
Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.
Source: FDA, updated November 16, 2026
Official labels and ingredient lists from DailyMed (U.S. National Library of Medicine).
120 mg delayed-release capsule
Verelan itself isn’t sold anymore, so there’s no current brand label to compare. Here’s the authorized generic’s label.
Active: verapamil hydrochloride 120 mg
Inactive:
180 mg delayed-release capsule
Verelan itself isn’t sold anymore, so there’s no current brand label to compare. Here’s the authorized generic’s label.
Active: verapamil hydrochloride 180 mg
Inactive:
240 mg delayed-release capsule
Verelan itself isn’t sold anymore, so there’s no current brand label to compare. Here’s the authorized generic’s label.
Active: verapamil hydrochloride 240 mg
Inactive:
360 mg delayed-release capsule
Verelan itself isn’t sold anymore, so there’s no current brand label to compare. Here’s the authorized generic’s label.
Active: verapamil hydrochloride 360 mg
Inactive:
Same active ingredient as Verelan. Fillers and dyes can differ.
Pharmacies’ own cash prices for generic verapamil, lowest first.
Pick up in storeDelivered
From each pharmacy’s own site, read November 17, 2026. Confirm the price before you fill.
Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.
2 companies sell a generic of Verelan that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.
Has dyes: D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Green No. 3, FD&C Red No. 40
120 mg Bluish green opaque and white opaque, capsule, 18 mm, marked “MYLAN / 6320”
| Package | NDC |
|---|---|
| Carton of 100 | 51079-917-20 |
Inactive ingredients: dibutyl sebacate, ammonia, diethyl phthalate, ethylcellulose, hypromellose, maltodextrin, methacrylic acid and ethyl acrylate copolymer, methacrylic acid - methyl methacrylate copolymer (1:2), oleic acid, polyethylene glycol, povidone, silicon dioxide, starch, corn, sucrose, talc, FD&C Green No. 3, gelatin, sodium lauryl sulfate, titanium dioxide, ferrosoferric oxide, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, propylene glycol, shellac
Has dyes: D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Green No. 3, FD&C Red No. 40
120 mg Bluish green opaque and white opaque, capsule, 18 mm, marked “MYLAN / 6320”
| Package | NDC |
|---|---|
| Bottle of 100 | 0378-6320-01 |
180 mg Bluish green opaque and light green opaque, capsule, 21 mm, marked “MYLAN / 6380”
| Package | NDC |
|---|---|
| Bottle of 100 | 0378-6380-01 |
240 mg Bluish green opaque, capsule, 22 mm, marked “MYLAN / 6440”
| Package | NDC |
|---|---|
| Bottle of 100 | 0378-6440-01 |
Inactive ingredients: ammonia, dibutyl sebacate, diethyl phthalate, ethylcellulose, hypromellose, maltodextrin, methacrylic acid and ethyl acrylate copolymer, methacrylic acid - methyl methacrylate copolymer (1:2), oleic acid, polyethylene glycol, povidone, silicon dioxide, starch, corn, sucrose, talc, FD&C Green No. 3, gelatin, sodium lauryl sulfate, titanium dioxide, ferrosoferric oxide, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, propylene glycol, shellac, sucralose
Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.
Verapamil hydrochloride sustained-release capsules are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug.
Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.
Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.
Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.
Source: the FDA label for Verapamil Hydrochloride (Wilshire Pharmaceuticals, Inc.), November 27, 2024. Full label on DailyMed
Prices checked November 17, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/verelan/